GTTRX
Price
$35.75
Change
+$0.07 (+0.20%)
Updated
Feb 4 closing price
Net Assets
955.37M
UBVVX
Price
$84.69
Change
+$2.51 (+3.05%)
Updated
Feb 4 closing price
Net Assets
9.23B
Interact to see
Advertisement

GTTRX vs UBVVX

Header iconGTTRX vs UBVVX Comparison
Open Charts GTTRX vs UBVVXBanner chart's image
Goldman Sachs Small Cp Val Insghts R
Price$35.75
Change+$0.07 (+0.20%)
VolumeN/A
Net Assets955.37M
Undiscovered Managers Behavioral Val R5
Price$84.69
Change+$2.51 (+3.05%)
VolumeN/A
Net Assets9.23B
GTTRX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
GTTRX vs. UBVVX commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTTRX is a Buy and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.23B vs. GTTRX (955M). GTTRX pays higher dividends than UBVVX: GTTRX (1.88) vs UBVVX (1.73). GTTRX was incepted earlier than UBVVX: GTTRX (18 years) vs UBVVX (9 years). GTTRX (1.50) is less costly to investors than UBVVX (0.94). GTTRX is a more actively managed with annual turnover of: 139.00 vs. UBVVX (35.00). GTTRX (0) and UBVVX (0) have matching initial minimum investment requirements. GTTRX annual gain was more profitable for investors over the last year : 13.68 vs. UBVVX (0.48). UBVVX return over 5 years is better than : 28.34 vs. GTTRX (-14.70).
GTTRXUBVVXGTTRX / UBVVX
Total Expense Ratio1.450.90161%
Annual Report Gross Expense Ratio1.500.94160%
Fund Existence18 years9 years-
Gain YTD9.4958.341114%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets955M9.23B10%
Annual Yield % from dividends1.881.73109%
Returns for 1 year13.680.482,862%
Returns for 3 years7.658.1594%
Returns for 5 years-14.7028.34-52%
Returns for 10 years24.11N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBHC13.100.94
+7.73%
Pathfinder Bancorp
PBM3.240.15
+4.85%
Psyence Biomedical Ltd.
BSRR37.911.01
+2.74%
Sierra Bancorp
TPB127.130.46
+0.36%
Turning Point Brands
RGC28.38-0.07
-0.25%
Regencell Bioscience Holdings Limited